For Week 2, you will examine how patient factors may influence pharmacokinetic and pharmacodynamic processes of pharmacotherapeutics used in the treatment of cardiovascular disorders. You also explore ways to improve drug therapy plans for cardiovascular disorders based on patient factors and overall health needs. When writing your Week 2 Assignment, consider the following scenario: Patient HM has a history of atrial fibrillation and a transient ischemic attack (TIA). The patient has been diagnosed with type 2 diabetes, hypertension, hyperlipidemia and ischemic heart disease. Drugs currently prescribed include the following: · Warfarin 5 mg daily MWF and 2.5 mg daily T, TH, Sat, Sun · Aspirin 81 mg daily · Metformin 1000 mg po bid · Glyburide 10 mg bid · Atenolol 100 mg po daily · Motrin 200 mg 1–3 tablets every 6 hours as needed for pain Must use 3 references from 2015 or newer MUST BE APA 7 FORMAT ATTACHED RUBRIC MUST BE FOLLOWED AND PROPER ENGLISH MUST BE USED….. Evidence-based clinical practice guidelines are fundamental to clinical practice, as they assist providers with clinical decision making. I have attached some applicable guidelines below for your reference. Have a great week! 2017 ACC-AHA Guideline Mgmt HTN in Adults.pdf 2018 AHA-ACC Guideline on Mgmt Blood Cholesterol.pdf 2017 ACC-AHA-HFSA Guideline Mgmt HF.pdf ASH 2018 Guidelines Mgmt of VTE_Optimal Anticoag.pdf 2019 AHA-ACC-HRS Guideline for Mgmt A Fib.pdf 2017 AHA-ACC Guideline Mgmt Valvular Heart Disease.pdf
4838
